LXRX logo

Lexicon Pharmaceuticals, Inc. (LXRX) Operating Profit

Annual Operating Profit:

-$184.82M-$13.07M(-7.61%)
December 31, 2024

Summary

  • As of today, LXRX annual operating income is -$184.82 million, with the most recent change of -$13.07 million (-7.61%) on December 31, 2024.
  • During the last 3 years, LXRX annual operating profit has fallen by -$97.73 million (-112.21%).
  • LXRX annual operating profit is now -208.66% below its all-time high of $170.08 million, reached on December 31, 2019.

Performance

LXRX Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLXRXincome statement metrics

Quarterly Operating Profit:

-$12.19M-$15.92M(-426.20%)
September 30, 2025

Summary

  • As of today, LXRX quarterly operating income is -$12.19 million, with the most recent change of -$15.92 million (-426.20%) on September 30, 2025.
  • Over the past year, LXRX quarterly operating profit has increased by +$51.51 million (+80.87%).
  • LXRX quarterly operating profit is now -104.81% below its all-time high of $253.31 million, reached on September 30, 2019.

Performance

LXRX Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLXRXincome statement metrics

TTM Operating Profit:

-$57.97M+$51.51M(+47.05%)
September 30, 2025

Summary

  • As of today, LXRX TTM operating income is -$57.97 million, with the most recent change of +$51.51 million (+47.05%) on September 30, 2025.
  • Over the past year, LXRX TTM operating profit has increased by +$153.15 million (+72.54%).
  • LXRX TTM operating profit is now -128.29% below its all-time high of $204.93 million, reached on September 30, 2019.

Performance

LXRX TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLXRXincome statement metrics

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

LXRX Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-7.6%+80.9%+72.5%
3Y3 Years-112.2%+47.2%+39.5%
5Y5 Years-208.7%+70.0%+72.8%

LXRX Operating Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-112.2%at low-426.2%+80.9%at high+72.5%
5Y5-Year-208.7%at low-426.2%+80.9%at high+72.8%
All-TimeAll-Time-208.7%at low-104.8%+80.9%-128.3%+72.8%

LXRX Operating Profit History

DateAnnualQuarterlyTTM
Sep 2025
-
-$12.19M(-426.2%)
-$57.97M(+47.0%)
Jun 2025
-
$3.74M(+114.5%)
-$109.47M(+35.1%)
Mar 2025
-
-$25.68M(-7.7%)
-$168.56M(+10.4%)
Dec 2024
-$184.82M(-7.6%)
-$23.84M(+62.6%)
-$188.22M(+10.8%)
Sep 2024
-
-$63.69M(-15.1%)
-$211.12M(-7.1%)
Jun 2024
-
-$55.35M(-22.1%)
-$197.06M(-6.0%)
Mar 2024
-
-$45.33M(+3.0%)
-$185.94M(-8.3%)
Dec 2023
-$171.75M(-70.5%)
-$46.74M(+5.8%)
-$171.75M(-10.6%)
Sep 2023
-
-$49.63M(-12.2%)
-$155.29M(-20.6%)
Jun 2023
-
-$44.24M(-42.1%)
-$128.75M(-18.6%)
Mar 2023
-
-$31.14M(-2.9%)
-$108.52M(-7.7%)
Dec 2022
-$100.76M(-15.7%)
-$30.28M(-31.1%)
-$100.76M(-5.2%)
Sep 2022
-
-$23.09M(+3.8%)
-$95.81M(-0.1%)
Jun 2022
-
-$24.01M(-2.7%)
-$95.68M(-6.7%)
Mar 2022
-
-$23.38M(+7.7%)
-$89.63M(-2.9%)
Dec 2021
-$87.09M(+49.7%)
-$25.33M(-10.3%)
-$87.09M(-26.2%)
Sep 2021
-
-$22.96M(-27.9%)
-$68.98M(+20.4%)
Jun 2021
-
-$17.96M(+13.8%)
-$86.67M(+34.2%)
Mar 2021
-
-$20.84M(-188.4%)
-$131.69M(+24.0%)
Dec 2020
-$173.28M(-201.9%)
-$7.22M(+82.2%)
-$173.28M(+18.8%)
Sep 2020
-
-$40.64M(+35.5%)
-$213.28M(-364.3%)
Jun 2020
-
-$62.98M(-0.9%)
$80.68M(-35.5%)
Mar 2020
-
-$62.44M(-32.2%)
$125.11M(-26.4%)
Dec 2019
$170.08M(+264.7%)
-$47.22M(-118.6%)
$170.08M(-17.0%)
Sep 2019
-
$253.31M(+1465.9%)
$204.93M(+387.4%)
Jun 2019
-
-$18.55M(-6.2%)
-$71.31M(+14.1%)
Mar 2019
-
-$17.47M(-41.3%)
-$83.03M(+19.6%)
Dec 2018
-$103.28M(+19.6%)
-$12.37M(+46.1%)
-$103.28M(+15.1%)
Sep 2018
-
-$22.93M(+24.3%)
-$121.70M(+5.1%)
Jun 2018
-
-$30.27M(+19.7%)
-$128.29M(+2.7%)
Mar 2018
-
-$37.71M(-22.5%)
-$131.91M(+2.0%)
Dec 2017
-$128.52M(+6.8%)
-$30.79M(-4.3%)
-$134.58M(+0.4%)
Sep 2017
-
-$29.52M(+12.9%)
-$135.13M(+5.3%)
Jun 2017
-
-$33.89M(+16.1%)
-$142.69M(+1.8%)
Mar 2017
-
-$40.38M(-28.9%)
-$145.34M(-5.4%)
Dec 2016
-$137.86M(-1354.2%)
-$31.33M(+15.5%)
-$137.86M(-29.4%)
Sep 2016
-
-$37.08M(-1.5%)
-$106.53M(-9.4%)
Jun 2016
-
-$36.54M(-11.1%)
-$97.37M(-11.2%)
Mar 2016
-
-$32.91M(-17.8%)
-$87.53M(-6.8%)
Dec 2015
$10.99M(+113.7%)
-
-
Sep 2015
-
-$27.92M(-4.6%)
-$81.94M(+0.2%)
Jun 2015
-
-$26.70M(-7.8%)
-$82.12M(-3.1%)
Mar 2015
-
-$24.77M(-876.5%)
-$79.68M(+0.7%)
Dec 2014
-$80.24M(+23.3%)
-$2.54M(+91.0%)
-$80.24M(+19.7%)
Sep 2014
-
-$28.11M(-15.8%)
-$99.96M(+1.7%)
Jun 2014
-
-$24.26M(+4.2%)
-$101.74M(+3.7%)
Mar 2014
-
-$25.33M(-13.8%)
-$105.62M(-1.0%)
Dec 2013
-$104.58M(-6.1%)
-$22.27M(+25.5%)
-$104.58M(+2.3%)
Sep 2013
-
-$29.88M(-6.1%)
-$107.01M(-6.6%)
Jun 2013
-
-$28.15M(-15.9%)
-$100.35M(-5.1%)
Mar 2013
-
-$24.29M(+1.6%)
-$95.52M(+3.1%)
Dec 2012
-$98.53M
-$24.69M(-6.4%)
-$98.53M(+6.0%)
Sep 2012
-
-$23.22M(+0.4%)
-$104.81M(+0.1%)
DateAnnualQuarterlyTTM
Jun 2012
-
-$23.32M(+14.6%)
-$104.95M(+0.8%)
Mar 2012
-
-$27.30M(+11.9%)
-$105.75M(+0.7%)
Dec 2011
-$106.53M(-14.5%)
-$30.97M(-32.6%)
-$106.53M(-7.0%)
Sep 2011
-
-$23.36M(+3.2%)
-$99.55M(+0.9%)
Jun 2011
-
-$24.12M(+14.1%)
-$100.44M(-0.0%)
Mar 2011
-
-$28.08M(-17.0%)
-$100.39M(-3.2%)
Dec 2010
-$93.01M(-3.4%)
-$23.99M(+1.1%)
-$97.28M(-2.3%)
Sep 2010
-
-$24.25M(-0.7%)
-$95.14M(-2.7%)
Jun 2010
-
-$24.07M(+3.6%)
-$92.64M(-1.4%)
Mar 2010
-
-$24.97M(-14.3%)
-$91.35M(-1.6%)
Dec 2009
-$89.96M(+6.8%)
-$21.85M(-0.4%)
-$89.96M(-1.1%)
Sep 2009
-
-$21.76M(+4.5%)
-$89.00M(+3.3%)
Jun 2009
-
-$22.78M(+3.3%)
-$92.06M(+3.8%)
Mar 2009
-
-$23.57M(-12.8%)
-$95.67M(+0.9%)
Dec 2008
-$96.53M(-28.8%)
-$20.89M(+15.8%)
-$96.53M(-2.6%)
Sep 2008
-
-$24.82M(+5.9%)
-$94.11M(-6.1%)
Jun 2008
-
-$26.39M(-8.0%)
-$88.73M(-10.5%)
Mar 2008
-
-$24.44M(-32.3%)
-$80.30M(-7.1%)
Dec 2007
-$74.95M(-35.7%)
-$18.47M(+5.0%)
-$74.95M(-5.5%)
Sep 2007
-
-$19.44M(-8.3%)
-$71.06M(-10.5%)
Jun 2007
-
-$17.95M(+6.0%)
-$64.32M(-1.6%)
Mar 2007
-
-$19.09M(-31.0%)
-$63.31M(-14.6%)
Dec 2006
-$55.23M(-52.9%)
-$14.57M(-14.7%)
-$55.23M(-58.1%)
Sep 2006
-
-$12.71M(+25.0%)
-$34.94M(+3.7%)
Jun 2006
-
-$16.93M(-53.7%)
-$36.29M(-7.1%)
Mar 2006
-
-$11.02M(-292.6%)
-$33.87M(+6.2%)
Dec 2005
-$36.12M(+23.9%)
$5.72M(+140.7%)
-$36.12M(+16.6%)
Sep 2005
-
-$14.05M(+3.2%)
-$43.30M(-0.2%)
Jun 2005
-
-$14.52M(-9.4%)
-$43.19M(+4.3%)
Mar 2005
-
-$13.27M(-809.9%)
-$45.12M(+4.9%)
Dec 2004
-$47.45M(+24.2%)
-$1.46M(+89.5%)
-$47.45M(+18.7%)
Sep 2004
-
-$13.95M(+15.2%)
-$58.34M(+1.6%)
Jun 2004
-
-$16.44M(-5.4%)
-$59.26M(+2.3%)
Mar 2004
-
-$15.60M(-26.4%)
-$60.66M(+3.1%)
Dec 2003
-$62.59M(+0.5%)
-$12.34M(+17.0%)
-$62.59M(+3.5%)
Sep 2003
-
-$14.87M(+16.7%)
-$64.84M(+3.9%)
Jun 2003
-
-$17.85M(-1.8%)
-$67.46M(-3.4%)
Mar 2003
-
-$17.53M(-20.2%)
-$65.25M(-3.7%)
Dec 2002
-$62.89M(-55.5%)
-$14.59M(+16.6%)
-$62.89M(-3.2%)
Sep 2002
-
-$17.49M(-11.8%)
-$60.93M(-18.6%)
Jun 2002
-
-$15.64M(-3.1%)
-$51.40M(-7.1%)
Mar 2002
-
-$15.18M(-20.2%)
-$47.99M(-10.0%)
Dec 2001
-$40.44M(-14.0%)
-$12.63M(-58.7%)
-$43.64M(-4.3%)
Sep 2001
-
-$7.96M(+35.0%)
-$41.85M(-7.9%)
Jun 2001
-
-$12.24M(-13.1%)
-$38.79M(-18.0%)
Mar 2001
-
-$10.82M(+0.2%)
-$32.86M(+7.4%)
Dec 2000
-$35.48M(-176.7%)
-$10.84M(-121.7%)
-$35.48M(-44.0%)
Sep 2000
-
-$4.89M(+22.5%)
-$24.64M(-24.8%)
Jun 2000
-
-$6.31M(+53.0%)
-$19.75M(-47.0%)
Mar 2000
-
-$13.44M
-$13.44M
Dec 1999
-$12.82M(-56.5%)
-
-
Dec 1998
-$8.19M(-49.6%)
-
-
Dec 1997
-$5.48M(-91.0%)
-
-
Dec 1996
-$2.87M
-
-

FAQ

  • What is Lexicon Pharmaceuticals, Inc. annual operating income?
  • What is the all-time high annual operating profit for Lexicon Pharmaceuticals, Inc.?
  • What is Lexicon Pharmaceuticals, Inc. annual operating profit year-on-year change?
  • What is Lexicon Pharmaceuticals, Inc. quarterly operating income?
  • What is the all-time high quarterly operating profit for Lexicon Pharmaceuticals, Inc.?
  • What is Lexicon Pharmaceuticals, Inc. quarterly operating profit year-on-year change?
  • What is Lexicon Pharmaceuticals, Inc. TTM operating income?
  • What is the all-time high TTM operating profit for Lexicon Pharmaceuticals, Inc.?
  • What is Lexicon Pharmaceuticals, Inc. TTM operating profit year-on-year change?

What is Lexicon Pharmaceuticals, Inc. annual operating income?

The current annual operating profit of LXRX is -$184.82M

What is the all-time high annual operating profit for Lexicon Pharmaceuticals, Inc.?

Lexicon Pharmaceuticals, Inc. all-time high annual operating income is $170.08M

What is Lexicon Pharmaceuticals, Inc. annual operating profit year-on-year change?

Over the past year, LXRX annual operating income has changed by -$13.07M (-7.61%)

What is Lexicon Pharmaceuticals, Inc. quarterly operating income?

The current quarterly operating profit of LXRX is -$12.19M

What is the all-time high quarterly operating profit for Lexicon Pharmaceuticals, Inc.?

Lexicon Pharmaceuticals, Inc. all-time high quarterly operating income is $253.31M

What is Lexicon Pharmaceuticals, Inc. quarterly operating profit year-on-year change?

Over the past year, LXRX quarterly operating income has changed by +$51.51M (+80.87%)

What is Lexicon Pharmaceuticals, Inc. TTM operating income?

The current TTM operating profit of LXRX is -$57.97M

What is the all-time high TTM operating profit for Lexicon Pharmaceuticals, Inc.?

Lexicon Pharmaceuticals, Inc. all-time high TTM operating income is $204.93M

What is Lexicon Pharmaceuticals, Inc. TTM operating profit year-on-year change?

Over the past year, LXRX TTM operating income has changed by +$153.15M (+72.54%)
On this page